Trial Profile
An Open-Label Clinical Trial With Split-virion Influenza A/H1N1 Vaccines in Healthy Elders.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 26 Apr 2013
Price :
$35
*
At a glance
- Drugs Influenza A virus vaccine-H1N1 (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions; Pharmacodynamics
- Sponsors Sinovac Biotech
- 08 Nov 2009 New trial record